2014
DOI: 10.5455/2320-6012.ijrms20141103
|View full text |Cite
|
Sign up to set email alerts
|

Linezolid resistant Staphylococcus aureus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…On the contrary, in the third world countries, reported resistance rates to linezolid have been steadily rising up (Meka and Gold, 2004). In India linezolid resistance ranged between 2-20% % (Gandham, 2014), and in Pakistan it ranged 35 and 48.1% (Azhar, et al, 2017;Wali et al, 2022).…”
Section: Discussionmentioning
confidence: 96%
“…On the contrary, in the third world countries, reported resistance rates to linezolid have been steadily rising up (Meka and Gold, 2004). In India linezolid resistance ranged between 2-20% % (Gandham, 2014), and in Pakistan it ranged 35 and 48.1% (Azhar, et al, 2017;Wali et al, 2022).…”
Section: Discussionmentioning
confidence: 96%
“…[8][9] In view of rising prevalence of MRSA and Methicillin resistant coagulase negative Staphylococcus, FDA approved Linezolid as the first antibiotic for use from the oxazolidinone class which acts by inhibition of protein synthesis. 10 Currently, emergence of linezolid resistant Staphylococcus species has been reported worldwide and is a cause of major concern. 11 The main mechanism of resistance is via the mutations in the V domain of the 23S rRNA.…”
Section: Introductionmentioning
confidence: 99%